Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Soliton Inc

(NASDAQ: SOLY)
Add to Portfolio
-0.28 (-2.06%)
as of Sep 20, 2019

Last 13.33
Change -0.28 (-2.06%)
Open 13.70
Prev. Close 13.61
Today's Range
13.20
13.82
52wk Range
4.12
29.00
Volume 554,500
Avg Volume 339,930
Sector SIC-3841 Surgical & Medical Instruments & Apparatus

Perfomance Comparison

Name Today 3-Month 1-Year
SOLY -2.06% -37.18% +173.72%
DJIA -0.59% -0.56% +1.04%
S&P 500 -0.49% -0.26% +2.09%

Key Statistics

Annual EPS N/A
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 218,970
Weighted Alpha +10.30
Standard Deviation -0.53
Profit Margin N/A
Beta N/A

Growth Rates

YTD +173.72%

Opinion

Sell Hold Buy

Recent Headlines

Soliton Begins Treatments In Proof-Of-Concept Trial

PR Newswire via COMTEX - Thu Sep 19, 08:45AM EDT
Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson")(full story)
SOLY: 13.33 (-0.28)

Soliton Completes Trial Enrollment and Conducts

PR Newswire via COMTEX - Tue Sep 17, 08:00AM EDT
Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson")(full story)
SOLY: 13.33 (-0.28)

Soliton Announces Site Selected for Clinical Trial to

PR Newswire via COMTEX - Tue Sep 10, 08:00AM EDT
Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson")(full story)
SOLY: 13.33 (-0.28)

Soliton Releases Letter to Shareholders

PR Newswire via COMTEX - Mon Sep 09, 08:00AM EDT
Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson")(full story)
SOLY: 13.33 (-0.28)

Soliton Announces IRB Approval for Keloid Trial

PR Newswire via COMTEX - Wed Sep 04, 08:00AM EDT
Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson")(full story)
SOLY: 13.33 (-0.28)